| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wilson Martin | General Counsel | C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY | /s/ Martin Louis Wilson | 18 Feb 2026 | 0001704342 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RCKT | Common Stock | Sale | $40,582 | -12,253 | -1.8% | $3.31 | 683,376 | 13 Feb 2026 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. |
| F2 | The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs. |